Climb In Consumer Self-Care, Slide In Rx Margin Boost Front-Of-Store Pharmacy Sales
This article was originally published in The Tan Sheet
Executive Summary
OTC drug and supplement marketers could benefit from stronger outreach to independent pharmacists, via product education and patient sales collateral, pharmacists say in a Healthcare Distribution Management Association survey.
You may also be interested in...
Pharmacy Interests Back BTC Models For Third Class
Retailers CVS and Walmart, as well as the National Association of Chain Drug Stores, advocate for a central role for pharmacists in enabling a new class of nonprescription drugs. In comments to FDA, NACDS also supports a switch model that will protect the existing OTC class.
Switch Sponsors Find Key Partners In Payers, Providers and Managed Care
Over-the-counter switch programs that engage health care professionals as partners generate two to three times the consumer awareness as those that do not, said Rohinish Hooda, VP of upper respiratory at McNeil Consumer Healthcare
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.